What is CLDI's earnings growth forecast for 2025-2025?
(NYSEMKT: CLDI) Calidi Biotherapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Calidi Biotherapeutics's earnings in 2025 is -$23,814,000.
In 2025, CLDI is forecast to generate -$12,810,411 in earnings, with the lowest earnings forecast at -$12,810,411 and the highest earnings forecast at -$12,810,411.
What is CLDI's forecast return on equity (ROE) for 2025-2025?
(NYSEMKT: CLDI) forecast ROE is -835.1%, which is considered weak.
What is CLDI's Earnings Per Share (EPS) forecast for 2025-2025?
(NYSEMKT: CLDI) Calidi Biotherapeutics's current Earnings Per Share (EPS) is -$2.97. In 2025, CLDI's EPS is forecast to hit -$0.45 (min: -$0.45, max: -$0.45).
What is CLDI's forecast return on assets (ROA) for 2025-2025?
(NYSEMKT: CLDI) forecast ROA is -90.33%, which is lower than the forecast US Biotechnology industry average of 84.94%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.